Total Payments
$187,287
2020 Payments
$19,022
Companies
6
Transactions
246
Payment Breakdown by Category
Other$144,140 (77.0%)
Travel$34,628 (18.5%)
Consulting$5,350 (2.9%)
Food & Beverage$3,169 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $144,140 | 60 | 77.0% |
| Travel and Lodging | $34,628 | 123 | 18.5% |
| Consulting Fee | $5,350 | 1 | 2.9% |
| Food and Beverage | $3,169 | 62 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $112,532 | 154 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $74,303 | 87 | $0 (2020) |
| Tandem Diabetes Care, Inc. | $142.03 | 2 | $0 (2018) |
| Medtronic MiniMed, Inc. | $123.73 | 1 | $0 (2017) |
| Valeritas, Inc. | $115.24 | 1 | $0 (2019) |
| Abbott Laboratories | $70.31 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $19,022 | 26 | AstraZeneca Pharmaceuticals LP ($13,930) |
| 2019 | $53,066 | 71 | AstraZeneca Pharmaceuticals LP ($29,207) |
| 2018 | $22,721 | 35 | Merck Sharp & Dohme Corporation ($12,197) |
| 2017 | $92,478 | 114 | Merck Sharp & Dohme Corporation ($71,501) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $33.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/19/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Consulting Fee | Cash or cash equivalent | $5,350.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/18/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/18/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $595.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $292.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $104.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $47.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $39.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | Cash or cash equivalent | $18.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/29/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/29/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $89.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $34.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | In-kind items and services | $32.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/28/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | In-kind items and services | $32.59 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. Tom Sauerwein, M.D
Dr. Tom Sauerwein, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Jbsa Lackland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265410567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tom Sauerwein, M.D has received a total of $187,287 in payments from pharmaceutical and medical device companies, with $19,022 received in 2020. These payments were reported across 246 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($144,140).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Jbsa Lackland, TX
- Active Since 01/06/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1265410567
Products in Payments
- JANUVIA (Drug) $89,356
- BYDUREON (Drug) $52,325
- STEGLATRO (Drug) $23,176
- FARXIGA (Drug) $21,878
- t-slim insulin pump (Device) $142.03
- Minimed 670G System (Device) $123.73
- V-GO (Device) $115.24
- FreeStyle Freedom Lite system (Device) $70.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.